bioMérieux announces nomination of two new Executive Committee members to lead Medical Affairs and R&D
Constant Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of TXA127 in Ischemic Stroke Recovery
ATL Technology: MD&M West 2024: Tech Talk and Meeting Registration
ARUP’s Julio Delgado, MD, MS, Selected as Inaugural Harry R. Hill, MD, Presidential Endowed Chair-Holder
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients.
Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates
Nusano Names Rohan Jain as Commercial General Manager.
Gibco CTS Cellmation Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing
Local Coverage Determination would result in contracted coverage for an estimated additional five million Medicare patients with Type 2 diabetes and early-stage chronic kidney disease
First Patient Enrolled in Merit Medical’s MOTION Study
bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
By allowing Carterra’s superior epitope, binding affinity, and kinetic information to occupy the same view as sequence information, the IGX Platform enables faster, better decision-making in therapeutic discovery.